How many drugs treat Edema?

Drug Landscape tracks 10 marketed treatments for Edema (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/edema.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Edema — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Edema (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Edema, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Midamor	AMILORIDE	Padagis Us	Potassium-sparing Diuretic	Amiloride-sensitive sodium channel, ENaC	1981-01-01
Edecrin	ETHACRYNIC ACID	Bausch Health	Loop Diuretic [EPC]	Glutathione S-transferase P	1967-01-01
Lasix	furosemide	Generic (originally Hoechst AG)	Loop Diuretic [EPC]	ATP-binding cassette sub-family G member 2, CDGSH iron-sulfur domain-containing protein 1, G-protein coupled receptor 35	1966-07-01
Aridol Kit	MANNITOL	Baxter	Osmotic Diuretic [EPC]	sodium channels	1964-01-01
Aldactone	spironolactone	Generic (originally Searle/Pfizer)	Aldosterone Antagonist [EPC]	Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2	1960-01-01
Combipres	Chlortalidone	University Hospital Birmingham	Thiazide-like Diuretic	Carbonic anhydrase 7	1960-01-01
Microzide	hydrochlorothiazide	Generic (originally Merck)	Thiazide Diuretic [EPC]	ACE	1959-01-01
Saluron	HYDROFLUMETHIAZIDE	Shire Llc	Thiazide Diuretic	Solute carrier family 12 member 3	1959-01-01
Diuril	CHLOROTHIAZIDE	Salix Pharms	Thiazide Diuretic	Solute carrier family 12 member 3	1958-01-01
Diamox	ACETAZOLAMIDE	Teva	Carbonic Anhydrase Inhibitor [EPC]	Carbonic anhydrase	1953-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 7 drugs in Edema
Baxter · 2 drugs in Edema
Bausch Health · 1 drug in Edema
Generic (originally Hoechst AG) · 1 drug in Edema
Generic (originally Merck) · 1 drug in Edema
Generic (originally Searle/Pfizer) · 1 drug in Edema
Medical University of Warsaw · 1 drug in Edema
Melbourne Health · 1 drug in Edema
Padagis Us · 1 drug in Edema
Salix Pharms · 1 drug in Edema
Second Xiangya Hospital of Central South University · 1 drug in Edema
Shire Llc · 1 drug in Edema

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Edema:

Cite this brief

Drug Landscape (2026). Edema — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/edema. Accessed 2026-06-10.

Edema full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing